Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02539719
Title Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Stemcentrx
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Fayetteville Arkansas 72703 United States Details
Duarte California 91010 United States Details
Chicago Illinois 60637 United States Details
Evanston Illinois 60208 United States Details
Boston Massachusetts 02114 United States Details
Detroit Michigan 48201 United States Details
Detroit Michigan 48202 United States Details
Rochester Minnesota 55905 United States Details
Saint Louis Missouri 63130 United States Details
New York New York 10065 United States Details
Columbus Ohio 43210 United States Details
Oklahoma City Oklahoma 73104 United States Details
Philadelphia Pennsylvania 19111 United States Details
Nashville Tennessee 37203 United States Details
Dallas Texas 75230 United States Details
Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field